Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Antiviral Res. 2020 Jul 16;181:104863. doi: 10.1016/j.antiviral.2020.104863

FIG 1.

FIG 1

Pyronaridine, tilorone and quinacrine efficacy and cytotoxicity dose response relationship against multiple strains of EBOV (Kikwit, Mayinga and Makona) and MARV (Musoke and Angola) in HeLa cells. (EBOV/Kik, Mak, May: MOI 0.21; MARV/Ang: MOI 021; MARV/Mus: MOI 0.4).